Johnson & Johnson reported FY2025 revenue of $94.2 billion, FY2025 net income of $26.8 billion and 2026 Q1 revenue of $24.1 billion. The thesis depends on pharma growth, medtech execution, litigation outcomes and cash conversion.
References
Sources used in this report
SEC datasetSEC company tickers exchange datasetRetrieved 2026-05-19 · Issuer identity, ticker, exchange and CIKSEC APISEC submissions APIRetrieved 2026-05-19 · Filing chronology and company identitySEC XBRL APISEC companyfacts APIRetrieved 2026-05-19 · Financial statement cross-checksAnnual reportFY2025 Form 10-K filed 2026-02-112026 · Annual business, risk and financial baselineQuarterly reportLatest Form 10-Q filed 2026-04-222026 · Latest interim financials and balance sheetForm 8-KForm 8-K filed 2026-04-282026 · Recent filing chronology and update contextProxy statementDEF 14A filed 2026-03-112026 · Governance and incentive framing